Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatuline Autogel in TME Post-operative Drainage
NCT01372007Phase 3Completed
- Sponsor
- Ghent University Hospital
- Start
- Jul 2011
- Primary completion
- Dec 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lanreotide in Rectal cancer (RC), sponsored by Ghent University Hospital. Started Jul 2011; status: completed.
02
Drugs
lanreotide
03
Conditions
Rectal cancer (RC)
Beyond the preview
Go deeper on NCT01372007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01372007.